Поиск

11}C- and {18}F-labelled tryptophans as PET-tracers for imaging of altered tryptophan metabolism in age-associated disorders

Авторы: Zlatopolskiy, B. D. Endepols, H. Krasikova, R. N. Fedorova, O. S. Ermert, J. Neumaier, B.
Краткая информация
Маркер записи n 22 3 4500
Контрольный номер uchm20_to89_no9_ss879_ad1
Дата корректировки 14:43:59 23 декабря 2020 г.
Кодируемые данные 201202s2020||||RU|||||||||||#||||# rus0|
Системный контрольный номер RUMARS-uchm20_to89_no9_ss879_ad1
AR-MARS
Служба первич. каталог. Научная библиотека Чувашского государственного университета
МАРС
Код языка каталог. rus
Код языка издания eng
eng
Индекс УДК 544
Индекс ББК 24.5
24.5
Таблицы для массовых библиотек
Таблицы для массовых библиотек
Zlatopolskiy, B. D.
PhD; Senior scientist
Institute of Neuroscience and Medicine at the Forschungszentrum Julich GmbH; Institute of Radiochemistry and Experimental Molecular Imaging at the University Clinic of Cologne
070
{11}C- and {18}F-labelled tryptophans as PET-tracers for imaging of altered tryptophan metabolism in age-associated disorders
B. D. Zlatopolskiy, H. Endepols, R. N. Krasikova [et al.]
Иллюстрации/ тип воспроизводства 18 рис.
Текст
непосредственный
Библиография Библиогр.: с. 893-896 (159 назв. )
Аннотация The ageing of the world's population is the result of increased life expectancy observed in almost all countries throughout the world. Consequently, a rising tide of ageing-associated disorders, like cancer and neurodegenerative diseases, represents one of the main global challenges of the 21st century. The ability of mankind to overcome these challenges is directly dependent on the capability to develop novel methods for therapy and diagnosis of age-associated diseases. One hallmark of age-related pathologies is an altered tryptophan metabolism. Numerous pathological processes including neurodegenerative and neurological diseases like epilepsy, Parkinson's and Alzheimer's diseases, cancer and diabetes exhibit marked changes in tryptophan metabolism. Visualization of key processes of tryptophan metabolic pathways, especially using positron emission tomography (PET) and related hybrid methods like PET/CT and PET/MRI, can be exploited to early detect the aforementioned disorders with considerable accuracy, allowing appropriate and timely treatment of patients. Here we review the published {11}C- and {18}F-labelled tryptophans with respect to the production and also preclinical and clinical evaluation as PET-tracers for visualization of different branches of tryptophan metabolism.
Химия
AR-MARS
Физическая химия в целом
AR-MARS
Ключевые слова возрастные заболевания
метаболизм триптофана
позитронно-эмиссионная томография
триптофаны
Endepols, H.
PhD; Professor
Institute of Radiochemistry and Experimental Molecular Imaging and the Department of Nuclear Medicine at the University Hospital Cologne
070
Krasikova, R. N.
PhD
Radiochemistry laboratory of N. P. Bechtereva Institute of Human Brain Russian Academy of Science
070
Fedorova, O. S.
PhD; Senior scientist
Radiochemistry laboratory of N. P. Bechtereva Institute of Human Brain Russian Academy of Science
070
Ermert, J.
PhD; Professor
Institute of Neuroscience and Medicine at the Forschungszentrum Julich GmbH
070
Neumaier, B.
PhD; Professor
Institute of Radiochemistry and Experimental Molecular Imaging at the University Clinic Cologne; Institute of Neuroscience and Medicine at the Forschungszentrum Julich GmbH
070
ISSN 0042-1308
Название источника Успехи химии
Место и дата издания 2020
Прочая информация Т. 89, № 9. - С. 879-896
RU
42813093
20201202
RCR
RU
42813093
20201202
RU
AR-MARS
20201202
RCR
RU
AR-MARS
20201202
Тип документа b
code
year
to
no
ss
ad
uchm
2020
89
9
879
1
244